Express News | Aadi Bioscience Inc : Jefferies Raises Target Price to $2 From $1.5
Aadi Biosciences | 10-Q: Q3 2024 Earnings Report
Aadi Biosciences | 8-K: Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Express News | Aadi Bioscience Remains Actively Engaged In A Comprehensive Strategic Review To Maximize Shareholder Value
Express News | Aadi Bioscience Is Completing Wind-down Of PRECISION1 Trial Of Nab-sirolimus In Patients With Solid Tumors Harboring TSC1 Or TSC2 Inactivating Alterations
Aadi Bioscience GAAP EPS of -$0.46 In-line, Revenue of $7.21M Beats by $0.61M
Aadi Bioscience 3Q Loss/Shr 46c >AADI
Earnings Flash (AADI) AADI BIOSCIENCE Reports Q3 Revenue $7.2M
Express News | Aadi Bioscience Q3 Operating Expenses USD 20.625 Million
Express News | Aadi Bioscience Q3 Product Sales USD 7.212 Million
Press Release: Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Earnings Preview: AADI to Report Financial Results on November 06
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
Express News | The Arbitration Panel Issued A Final Award Which Found And Concluded That Aadi Bioscience Did Not Breach The EOC Pharma License Agreement And Accordingly Is Not Liable For Any Damages To EOC - Filing
Aadi Bioscience Downgraded to Neutral, Shares Fall
Piper Sandler Downgrades Aadi Biosciences(AADI.US) to Hold Rating, Cuts Target Price to $1.75
Express News | Aadi Bioscience Inc : Piper Sandler Cuts to Neutral From Overweight
Express News | Aadi Bioscience Inc - Desai Will Continue to Serve as a Member of Board
Express News | Aadi Bioscience Inc - on August 20, Neil Desai, Was Notified That His Employment as Executive Chairman of Company Will Cease on October 1, 2024
Express News | Aadi Bioscience Inc - Board Has Determined That Itri's Pending Cessation of Employment Is a Voluntary Resignation